[
  {
    "ts": null,
    "headline": "3 Dividend Growth Stocks To Buy and Hold Forever",
    "summary": "These three companies have a high 5-year dividend yield, providing long-term stability while maximizing income.",
    "url": "https://finnhub.io/api/news?id=1acc30a832df0e5dce4ad0800113eb40f9042a1dbfabb59a97340b2c1f747bff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750188175,
      "headline": "3 Dividend Growth Stocks To Buy and Hold Forever",
      "id": 135340447,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "These three companies have a high 5-year dividend yield, providing long-term stability while maximizing income.",
      "url": "https://finnhub.io/api/news?id=1acc30a832df0e5dce4ad0800113eb40f9042a1dbfabb59a97340b2c1f747bff"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories stock outperforms competitors despite losses on the day",
    "summary": "Abbott Laboratories stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=d9284cfe80b03d191711bef82bcb712389f42864436f3a0659ad95aeb05d3cde",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750177980,
      "headline": "Abbott Laboratories stock outperforms competitors despite losses on the day",
      "id": 135355402,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=d9284cfe80b03d191711bef82bcb712389f42864436f3a0659ad95aeb05d3cde"
    }
  },
  {
    "ts": null,
    "headline": "Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management",
    "summary": "Abbott Laboratories (NYSE:ABT) is one of the best stocks to buy for beginners now. On June 10, Tandem Diabetes Care Inc. (NASDAQ:TNDM) announced a new agreement with Abbott to develop and commercialize integrated diabetes solutions. The collaboration will combine Abbott’s future dual glucose-ketone sensor with Tandem’s innovative insulin delivery systems, with the aim of providing […]",
    "url": "https://finnhub.io/api/news?id=8ef748e4de9306238af93d5097e310c07a814ff595a89a43b203315c0b4ef9b1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750141432,
      "headline": "Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management",
      "id": 135317789,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (NYSE:ABT) is one of the best stocks to buy for beginners now. On June 10, Tandem Diabetes Care Inc. (NASDAQ:TNDM) announced a new agreement with Abbott to develop and commercialize integrated diabetes solutions. The collaboration will combine Abbott’s future dual glucose-ketone sensor with Tandem’s innovative insulin delivery systems, with the aim of providing […]",
      "url": "https://finnhub.io/api/news?id=8ef748e4de9306238af93d5097e310c07a814ff595a89a43b203315c0b4ef9b1"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings?",
    "summary": "Abbott Laboratories has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 17.8% and now trades at $133.43. This performance may have investors wondering how to approach the situation.",
    "url": "https://finnhub.io/api/news?id=d41a111935d2857ac7ec60e763a361919f486a581de29c7f3530611a9f7f58a9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750132904,
      "headline": "Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings?",
      "id": 135338731,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 17.8% and now trades at $133.43. This performance may have investors wondering how to approach the situation.",
      "url": "https://finnhub.io/api/news?id=d41a111935d2857ac7ec60e763a361919f486a581de29c7f3530611a9f7f58a9"
    }
  }
]